| Product Code: ETC11423146 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Advanced Therapy Medicinal Products CDMO Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Advanced Therapy Medicinal Products CDMO Market - Industry Life Cycle |
3.4 South Korea Advanced Therapy Medicinal Products CDMO Market - Porter's Five Forces |
3.5 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.7 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Korea Advanced Therapy Medicinal Products CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in South Korea driving demand for advanced therapy medicinal products (ATMPs) CDMO services. |
4.2.2 Growing investments in research and development of ATMPs in South Korea. |
4.2.3 Favorable government regulations supporting the development and commercialization of ATMPs in the country. |
4.3 Market Restraints |
4.3.1 High costs associated with the development and manufacturing of ATMPs may hinder market growth. |
4.3.2 Complexity and long approval process for ATMPs may pose challenges for market expansion in South Korea. |
5 South Korea Advanced Therapy Medicinal Products CDMO Market Trends |
6 South Korea Advanced Therapy Medicinal Products CDMO Market, By Types |
6.1 South Korea Advanced Therapy Medicinal Products CDMO Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.4 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Cell Therapy, 2021 - 2031F |
6.1.5 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Tissue-Engineered Products, 2021 - 2031F |
6.2 South Korea Advanced Therapy Medicinal Products CDMO Market, By Service |
6.2.1 Overview and Analysis |
6.2.2 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.2.3 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Research & Development, 2021 - 2031F |
6.2.4 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 South Korea Advanced Therapy Medicinal Products CDMO Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
6.3.4 South Korea Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Hospitals & Clinics, 2021 - 2031F |
7 South Korea Advanced Therapy Medicinal Products CDMO Market Import-Export Trade Statistics |
7.1 South Korea Advanced Therapy Medicinal Products CDMO Market Export to Major Countries |
7.2 South Korea Advanced Therapy Medicinal Products CDMO Market Imports from Major Countries |
8 South Korea Advanced Therapy Medicinal Products CDMO Market Key Performance Indicators |
8.1 Number of ATMP clinical trials initiated in South Korea. |
8.2 Rate of adoption of ATMP manufacturing technologies in the country. |
8.3 Percentage of government funding allocated to support ATMP research and development initiatives. |
8.4 Number of partnerships and collaborations between South Korean CDMOs and international biopharmaceutical companies for ATMP production. |
9 South Korea Advanced Therapy Medicinal Products CDMO Market - Opportunity Assessment |
9.1 South Korea Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 South Korea Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.3 South Korea Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Korea Advanced Therapy Medicinal Products CDMO Market - Competitive Landscape |
10.1 South Korea Advanced Therapy Medicinal Products CDMO Market Revenue Share, By Companies, 2024 |
10.2 South Korea Advanced Therapy Medicinal Products CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here